IST:GENIL

Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret A.S. · IST · Healthcare · TRY · FY for 2025

Figures on this page computed 2026-11-08 12:42 UTC

Last close

n/aTRY

Market data

28.7xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
TRY
- computed
- Computed from the filing for 2025
10.0%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
4.3%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
4.5%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
0.30Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
TRY
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
TRY
- computed

Safety is the furthest below its sector's middle: 0.49 against 0.57 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

All from 100

lens 2 of 9

Sales

1,625

2018-12-31 to 2025-12-31100 at the start1,625

Sales: 100.00 on 2018-12-31 to 1624.95 on 2025-12-31, up 1525%.

Profit

12,483

2018-12-31 to 2025-12-31100 at the start12,483

Profit: 100.00 on 2018-12-31 to 12483.10 on 2025-12-31, up 12383%.

Shares in issue

715

2020-12-31 to 2025-12-31100 at the start715

Shares in issue: 100.00 on 2020-12-31 to 715.07 on 2025-12-31, up 615%.

Sales is at 1625, Profit is at 12483, Shares in issue is at 715, against 100 in 2018.

Sales is at 1625, Profit is at 12483, Shares in issue is at 715, against 100 in 2018.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 1001,625
Source
computed
Statement
income
Fiscal year
2025
Reported in
TRY
Profit, where the first year is 10012,483
Source
computed
Statement
income
Fiscal year
2025
Reported in
TRY
Shares in issue, where the first year is 100715
Source
computed
Statement
income
Fiscal year
2025
Reported in
TRY